NeOnc Technologies (NTHI) announced the official incorporation of NuroMENA Holdings by the Abu Dhabi Global Market, ADGM. With this regulatory milestone completed, all contingencies have now been met to finalize the previously announced $50 million cornerstone investment effort led by Quazar Investment into NuroMENA Holdings. This strategic partnership will support the launch of NeOnc’s innovative CNS platform across the MENA region and help to accelerate development of its therapeutic pipeline, including the NEO212 and NEO100 clinical programs.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTHI:
- NeOnc Technologies awarded $2.5M in NIH STTR grants
- NeOnc Technologies Acquires AI and Quantum IP Portfolio
- NeOnc Technologies Signs Definitive Agreement for Acquisition
- NeOnc to acquire AI, 3D, quantum modeling IP portfolio from Puri
- NeOnc signs definitive agreement for $50M strategic partnership with Quazar